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Eight 3-cyano-4-thiornethyl-6-aryl-2H-pyran-2-ones 1-8 and .three 3-cyano-4-(N,N-dimethyl)amino-6-
aryl-2H-pyran-2-ones 9-11 have been synthesised and their detailed mass fragmentation pattern alongwith
the X-ray crystal structure of a novel pyrone 5 have been studied. In addition, a comparative EIMS
behaviour of 3,5-disubstituted pyrazoles 16-23 and isoxazoles 12-15 is reported. The pyrazole derivative
23 has been found to possess strong anti-invasive activity against human breast carcinoma cells.
3-Cyano-4-thiomethyl-6-aryl-2H-pyran-2-ones are
well-known starting materials for the synthesis of a
variety of heterocyclic compounds 1.2. We are
engaged in a research programme involving
synthesis of pyrazolyl- and isoxazolyl-coumarins
and their analogs for structure-activity relationship
studies as potential biologically active compounds.
During the course of synthesis of the starting
pyrones 1-8, we obtained minor side products in
three cases, -which Were characterized as the
corresponding 3-cyano-4-(N,N-dimethylamino)-6-
aryl-2H-pyran-2-ones 9-11. As the detailed mass
spectral fragmentation pattern of the compounds
1-11 has not been reported earlier, we herein report
the unusual behaviour of these compounds under
electron impact. We have also carried out the
comparative ElMS studies on the fragmentation
pattern of the isoxazoles 12-15 and the pyrazoles
16-23, synthesised from the pyrones 1-8. The
pyrazole 23 has shown strong anti-invasive activity
against human breast carcinoma cells. The
molecular structure of 5 has been confirmed by an
X-ray crystallographic investigation.
Results and Discussion
The compounds 1-8 were synthesised by the
method reported earlier'". During the synthesis of


























product, characterized as 9,10 and 11, respectively.
The spectral data of these compounds alongwith
the X-ray crystal structure of5 (Figure 1) are being
reported here (cf. Experimental).
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Figure I-Molecular structure of 5 showing the numbering
scheme of the non-hydrogen atoms. The hydrogen atoms are
represented by small circles
We have synthesised 3,5-disubstituted isoxa-
zoles 12-15 and pyrazoles 16-23 via an efficient
method using the pyrones 1-8 as the starting
materials involving modification of the literature
procedures'? for the preparation of these
compounds. The compounds 5,7,10,12,14,20 and
22 are new compounds and have been synthesised
by us for the first time.
Compounds 1-8 behaved quite unusually
towards EIMS in the sense that they invariably
+ )+showed peaks at m/z (M-71) and (M-I03 .
These peaks seem to be the result of a complex
rearrangement, presumably by a mechanism
involving the McLafferty type migration of a
proton from -S-CH3 to the nitrile function with
simultaneous loss of HCN and CO2 (Scheme I)
producing a fragment which accounts for (M-71 r
peak. This fragment subsequently loses sulphur
forming a fragment accounting for the peak at m/z
(M-I03t. Apart from these peaks, other important
peaks are easily accountable and are in agreement
with the mass spectra of a similar compound 4-
methoxy-6-methyl-2-pyrone reported earlier6. The
molecular ions lose the aryl radical giving rise to a
peak at m/z 166; this fragment undergoes
rearrangement and loses C202, when a fragment
ion at m/z 110 is formed (Scheme II). 2-Pyrones
are also known to lose CO and so do our
compounds giving rise to peaks at m/z (M-28t;
the peaks due to loss of CH3 radical at m/z (M-
15)+,and peaks for ArCO+ and Ar+ moities are also
quite expected, and observed in our compounds
(Scheme II). The detailed MS data and respective
relative intensities of different prominent peaks in
compounds 1-8 are given in Table I.
Compounds 9-11 behaved similarly to EIMS as
did compounds 1-8. They showed a characteristic
but unusual peak at m/z (M-71t, formation of
which can be accounted through the pathway
exactly similar to that of 3-cyano-4-thiomethyl-6-
aryl-2H-pyran-2-ones 1-8 as depicted in Scheme I.
Remaining peaks are consistent with the pattern
reported earlier':" and the ones exhibited by
compounds 1-8 (Schemes I and II). The mass
spectrometric data and the relative intensities of
peaks observed in compounds 9-11 are given in
Table II.
The molecular ion. peak appeared as a strong
peak in isoxazoles 12-15 and as the base peak in
pyrazoles 16-23. This indicated the immense
stability of these heterocyclic systems. The base
peak in isozaxoles at m/z (M-40)+ was due to a
fragment obtained by the loss of -CH2CN radical
(Scheme III). The peak due to the loss of CN group
at m/z (M-26t was observed in pyrazoles
(Scheme IV; Table IV), but not in isoxazoles. The
peak at m/z (M-55t in the mass spectra of
pyrazoles is accounted via a rearrangement
pathway through the formation of a six-membered
diazine ring accompanied by loss of N2H radical
(Scheme IV). Such a rearrangement and loss are
known to occur in similar systems". Peaks for (M-
40t, (M-79t and Ar-+' fragments in case of
compounds 21 and 22 are not observed because a
different pathway of fragmentation is prevalent
here. The molecular ion first loses CH3 radical
from the methoxy group in the benzenoid ring
giving rise to a peak at m/z (M-15t, followed by
loss of CO accounting for a peak at m/z (M-43t.
The detailed fragmentation mechanisms of
isoxazoles and pyrazoles are shown in Schemes III
and IV, respectively and their MS data are given in
Tables III and IV, respectively. The molecular
structure of 5, as determined by an X-ray
investigation is illustrated in Figure I; all
crystallographic data, bond lengths and angles
(Tables V-VII) are unexceptional.
The fragmentation pathways depicted in this
paper could fmd utility in the identification of new
analogs of these compounds. The aryllactones 1-8
show quite identical features in their EI mass
spectra which bear two unusual peaks, which may
be used as diagnostic peaks for such types of
compounds. Though the isoxazoles and pyrazoles






Scheme I-ElMS rearrangement-fragmentation mechanism of compounds 1-8
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Scheme II-ElMS fragmentation pathways of compounds 1-8
Table I-Major ions (with relative intensities in parentheses) in ElMS of compounds 1-8 (values in m1z)
Compd M+ (M-15f (M-28f (M-71)+ (M-I03f ArCO+ (M-Arf Ar+ (M-
ArCO-
CO)+
1 243(79) 228(\ I) 215(88) 172(27) 140(17) 105(88) 166(7) 77(100) 110(13)
2 261(72) 246(9) 233(72) 190(32) 158(16) 123(100) 166(5) 95(83) 110(10)
3 277/279 2621264 2491251 206/208 174/176 139/141 166(19) 111/113 110 (9)
(89/30) (9/3) (66/22) (15/5) (6/2) (100/33) (57/19)
4 3211323 306/308 293/295 250/252 218/220 183/185 166 (14) 155/157 110 (13)
(99/100) (717) (63/64) (9/10) (6/6) (60/61) (42/43)
5· 3211323 306/308 293/295 2501252 218/220 183/185 166 (9) 155/157 110 (4)
(45/45) (4/4) (25/25) (3/3) (3/3) (22122) (15/15)
6 273 (100) 258 (6) 245 (56) 202 (9) 170 (9) 135 (60) 166 (5) 107 (22) 110 (4)
7 273 (100) 258 (4) 245 (65) 202 (15) 170(10) 135 (81) 166 (2) 107 (6) 110 (7)
8 257 (100) 242 (8) 229 (61) 186 (10) 154 (7) 119 (60) 166 (3) 91 (37) 110 (3)
·Base peak in the mass spectrum of this compound appeared at m/z 18
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Table II-Major ions (with relative intensities in parentheses) in ElMS of compounds 9-1 J (values in mlz)
Compd M+ (M-28f (M-71)+ (M-Arf (M- (M- ArCO+ Ar+
ArCot x-co-
cof
9 240 (47) 212 (15) 169 (8) 163 (7) 135(4) 107 (13) 105 (100) 77 (85)
10 318/320 290/292 247/249 163 (31) 135 (II) 107 (16) 183/185 155/157
(99/1 00) ( 19/19) (5/5) (80/80) (28/28)






























Scheme IV-ElMS fragmentation mechanism of compounds 16-23






Table III-Major ions (with relative intensities in parentheses) in ElMS of compounds 12-15 (values in mlz)
M+ (M-4ot (M-68t (M-95t Ar+
184 (46) 144 (100) 116 (14) 89 (6) 77 (38)
218/220(50/17) \781180(100/33) 150/152(28/9) 1231125(7/2) 1111113(1)
214(82) 174(100) 146(63) 119(5)
198 (55) 158 (100) 130 (19) 103 (3) 91 (21)
Table IV-Major ions (with relative intensities in parentheses) in ElMS of compounds 16-23 (values in mlz)
Compd M+ (M-26)+ (M-40t (M-55t (M-79t Ar+
16 183 (100) 157 (12) 143 (13) 128 (34) 104 (12) 77 (29)
17 201 (100) 175 (3) 161 (5) 146(10) 122 (4) 95 (4)
18 217/219 19)1193 (4/1) 177/179 (6/2) 1621164 (11/4) 138/140 (411) 1111113(5/2)
(100/33)
19 2611263 235/237 (414) 221/223 (616) 206/208 (919) 1821184 (4/4) 1551157
(100/100) (I6116)
20 261/263 235123 7 (2/2) 221/223 (212) 2061208 (212) 1821184 (3/3) 1551157
(100/100) (10/10)
21 213 (100) 187 (2) 158 (2)
22 213 (100) 187 (2) 158 (2)


















e range for data
collection






a = 36.59 (3) A
b=4.719(4)A
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2.23 to 23.05°
reported in this investigation are skeletonwise
similar, but there is marked difference in their
mass spectra; fragmentation of isoxazoles is
simple and easily accountable while that of
pyrazoles proceeds via a rearrangement. The
pyrazoles and isoxazoles reported in this paper are
being used by us in the synthesis of some novel
heterocyclic compounds, i.e. pyrazolyl/isoxazolyl
styrenes, coumarins, chromanones and triazoles for
structure-activity relationship studies.
Experimental Section
General. Mass spectra were recorded on an
MS-SO mass spectrometer using direct insertion
probe at 70 eV. The source temperature was 300°C
and the probe temperature W:}~ ISO-17SoC for
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Table VI-Atomic coordinates (x 104) and equivalent
isotropic displacement parameters (A 2 x 103) for 5. U(eq) is
defined as one third of the trace of the orthogonalized Uij
tensor
x y z U(eq)
Br 2294(1) -56(2) 1637(1) 42(1)
S(I) 390(1) -12170(4) -354(1) 36(1)
0(1) 1304(1) -8108(11 ) 1430(3) 29(1)
0(2) 1181(2) -10805(13) 2630(4) 42(2)
N(I) 430(3) -15371(15) 1896(6) 52(2)
C(I) 1991 (2) -1858(15) 688(5) 29(2)
C(2) 2017(2) -1153(18) -238(6) 37(2)
C(3) 1789(2) -2408(18) -903(6) 39(2)
C(4) 1538(2) -4386(17) -667(6) 34(2)
C(5) 1515(2) -5185(13) 249(5) 23(2).
C(6) 1749(2) -3894(16) 939(5) 29(2)
C(7) 1251(2) -7341(15) 511(5) 25(2)
C(8) 981(2) -8486(15) -41(5) 27(2)
C(9) 746(2) -10614(14) 301(5) 26(2)
C(1O) 814(2) -11458(15) 1218(5) 26(2)
C(II) 1099(2) -10266(14) 1820(5) 27(2)
C(l2) 602(2) -13661 (17) 1605(6) 34(2)
C(13) 336(3) -10059(16) -1389(6) 41(2)











C(7)-O(l )-C( II ) 122.1(6)
C(6)-C( I)-Br (18.7(6)
0(2)-C( Il)-O( I) 115.7(7)
N( I )-C( 12)-C( I0) 178.7(9)
compounds 1-8, 200°C for 9-11, 80°C for 12-15
and 100°C for 16-23 and the data obtained are
given in Tables I-IV.
Melting points were determined in a sulphuric
acid-bath and are uncorrected. IR spectra were
recorded (KBr pellet or film) on a Perkin-Elmer
1720 FT-IR spectrophotometer and UV spectra on
a Beckmann UV spectrophotometer. IH and 13C
NMR spectra were recorded on a Bruker AC-250
spectrometer at 250 and 62.5 MHz, respectively.
General procedure for the preparation of 3-
cyano-4-thiomethyl-6-aryl-2H-pyran-2-ones 1-8.
Ethyl 2-cyano-3,3-bis(thiomethy1)propenoatel
(4'.34 g, 0.02 mole) was dissolved in DMF (40
mL), and KOH (2.24 g, 0.04 mole) added to it. The
solution was stirred for 10 min. The corresponding
acetophenone (0.02 mole) was added and air
sucked from RB flask using a septutn and syringe.
The contents were stirred for 6 hr at 28-30°C. The
reddish-brown coloured supernatant was poured on
to crushed ice (200 g) and the contents were stirred
for 4 hr when a yellow solid precipitated out. It
was filtered, dried and purified by column chro-
matography, followed by crystallization from
acetone.
General procedure for the preparation of [3-
arylisoxazol-5-yl] acetonitriles 12-15. 6-AryI-4-
thiomethyl-2-oxo-2H-pyran-3-carbonitrile (6 m
moles) was dissolved in pyridine (I5 mL) at 70-
80°C, hydroxylamine hydrochloride (7 m moles),
added to it and the reacton mixture stirred for 40-
48 hr at 70-80°C; the earlier procedure involved
refluxing conditions. Pyridine was distilled off
under reduced pressure and the residue taken up in
ethyl acetate, washed with water, dil HCI and dried
over Na2S04• The gummy mass, thus obtained on
removal of ethyl acetate was subjected to column
chromatography over silica gel. The compounds
were eluted by ethyl acetate-pet. ether (I0-15%
v/v) and were obtained in higher yields as
compared to those reported earlier (35-45%,
literature yields 20-30%).
General procedure for the preparation of [5-
arylpyrazol-3-yl]acetonitriles 16-23. 6-AryI-4-
thiomethyl-2-oxo-2H-pyran-3-carbonitrile (6 m
moles) was dissolved in methanol (30 mL),
hydrazine hydrate (15 m moles) added to. it and the
contents were refluxed for 1-2 hr. The reaction
mixture was concentrated under reduced pressure
and poured over crushed ice (200 g). The contents
were stirred vigorously when a brownish-yellow
solid precipitated out. It was filtered, washed with
water, dried and column chromatographed over
silica gel. Using ethyl acetate-petroleum ether (I 0-
20% v/v) as eluent, a white solid was obtained
which was crystallized from acetone.
3-Cyano- 4 -thiomethyl- 6 -(3-bromophenyl)-
2H-pyran-2-one 5. Yellow shiny needles from
acetone, yield 60%, m.p. 233-35°; UV(MeOH):
Amax 209, 239, 251, 323 and 362 nm; IR (KBr):
2250, 1720, 1600, 1560, 1495, 1420, 1340, 1220,
1190, 1180 and 1060 cm"; IH NMR (DMSO-d6):
82.85 (3H, s, S-CH3), 7.30 (IH, s, H-5), 7.54 (IH,
m, H-5'), 7.81 (lR, m, R-6'), 8.00 (lR, m, H-4')
and 8.25 (IH, s, H-2'); I3C NMR (DMSO-d6): 8
14.36 (-SC1I3), 89.85(C-3), 100.43(C-5),








3-Cyano- 4 -thiomethyl- 6 -(3-methoxyphenyl-
2H-pyran-2-one 7. Yellow shiny needles from
ethyl acetate, yield 57%, m.p. 190°; UV(MeOH):
Amax 215, 251, 321 and 368 nm; IR(KBr): 2280,
1720, 1580, 1490, 1435, 1325, 1300, 1275, 1245,
1200, 1160 'and 1035 cm"; IH NMR (DMSO-d6):
8 2.73 (3H, s, S-CH3), 3.88 (3H, s,'OCH3), 6.73
(IH, s, H-5), 7.12(lH, m, H-5'), 7.41 (lH, s, H-2')
and 7.43 (2H, m, H-4' and 'H-6'); 13C NMR
(DMSO-d6): 8 14.70 (SCH3), 55.53 (OCH3),
98.24(C-3), 111.92(C-2' and C-5), 113.22(C=N),
118.54(C-4'), 118.92(C-6'), 130.28(C-5'),
131.02(C-l'), 160.14(C-3' and C-6), 161.78(C-4)
and 169.83(C=O).
3-Cyano- 4 -(N, N-dimethylamino)-6-(3-bromo-
phenyl)-2H-pyran-2-one 10. Reddish-yellow
shiny needles from acetone, yield 5%, m.p. 263~
65°; UV(MeOH): Amax 232, 245 and 305 nm;
IR(KBr): 2240, 1690, 1640, 1570, 1470, 1415,
1360, 1260, 1240, 1210, 1180, 1140 and 1070
cm "; IH NMR (DMSO-d6): 8 3.41 (6H, s,
N(CH3)2), 7.00 (lH, s, H-5), 7.50 OH, m, H-5'),
7.75 (lH, m, H-6'), 7.92 (lH, m, H-4') and 8.18
(lH, m, H-2'); 13C NMR (DMSO-d6): 8
42.51 [N(CH3)2], 96.21(C-3 and C-5),
117.97(C=N), 122.34(C-3'), 125.22(C-6'),
128.68(C-2'), 131.11 (C-5'), 132.82(C-1 '),
134.25(C-4'), 156.79(C-6), 159.99(C-4) and
161.60( C=O).
S-Cyanomethyl-3-phenylisoxazole 12. White
shiny needles from chloroform, yield 39%, m.p.
83-84°; UV (MeOH): Amax 205 and 240 nm;
IR(KBr): 2920, 2900, 2260, 1620, 1595, 1480,
1420 and 1395 cm'"; IH NMR (DMSO-d6): 84.50
(2H, s, CH2CN), 7.08 (JH, s, H-4), 7.52 (3H, m, H-
3', H-4' and H-5') and 7.89 (2H, m, H-2' and H-6'):
I3C NMR (DMSO-d6): 8 15.80 (CH2CN)' 101.55
(C-4), 115.70 (C=N) , 126.60(C-3' and C-5'),
127.95(C-1'), 129.08 (C-2' and C-6'), 130.39 (C-
4'), 162.34 (C-5) and 163.18 (C-3).
S-Cyanomethyl- 3 -(4-methoxyphenyl)isoxazole
14. White shiny needles from chloroform, yield
40%, m.p. 103-104°; UV (MeOH): Amax 216, 258
and 263 nm; IR(KBr): 3000, 2900, 2300, 1620,
1580, 1540, 1460, 1440, 1380, 1300 and 1260
cm'"; IH NMR (CDCI3): 8 3.85 (3H, s, OCH3),
3.92 (2H, s, -CH2CN), 6.60 (lH, s, H-4), 6.97 (2H,
d, J=9Hz, H-3' and H-5') and 7.71 (2H, d, J=9Hz,
H-2' and H-6'): 13C NMR (CDCI3): 8 16.69
(CH2CN), 55.36 (OCH3), 101.59 (C-4), 113.21
(C=N), 114.45 (C-3' and C-5'), 122.62 (C-l '),
128.25 (C-2' and C-6'), 161.12 (C-4' and C-5) and
165.31 (C-3).
3-Cyanomethyl-S-(3-bromophenyl)pyrazole 20.
White shiny needles from acetone, yield 40%, m.p.
142-144°; UV (MeOH): Amax 240, 246, 258, 269
and 279 nm;: !R(KBr): 3200, 2900, 2260, 1580,
1560, 1490, 1415, 1270, 1175 and 1010 cm'"; IH
NMR (acetone-zz.): 8 4.11 (2H, s, CH2 CN) , 6.89
(lH, s, H-4), 7.51 (lH, m, H-5'), 7.64 (lH, m, H-
6'), 7.90 (lH, m, H-4'), 8.11 (lH, s, H-2') and 12.63
(lH, brs, NH); 13C NMR (acetone-zz.): 8 16.67
(CH2CN), 102.51 (C-4), 117.42 (C=N) , 122.78 (C-
3'), 124.45 (C-2' and C-4'), 128.28 (C-5') and
131.08 (C-l' and C-6').
3-Cyanomethyl- 5 -(3-methoxyphenyl)pyrazole
22. White shiny needles from acetone, yield 52%,
m.p. 151°; UV (MeOH): Amax 206, 240, 246, 270
and 289 om; IR(KBr): 3200, 3000, 2300, 1600,
1580, 1420, 1290, 1220, 1185 and 1160 cm'"; IH
NMR (acetone-d.): 8 3.97 (3H, s, OCH3), 4.07
(2H, s, CH2CN), 6.81 (lH, s, H-4), 7.05 (lH, s, H-
2') and 7.48 (3H, m, H-4', H-5' and H-6'); I3C
NMR (acetone-zi.): 8 16.45 (CH2CN), 55.01
(OCH3), 102.01 (C-4), 110.85 (C-4'), 114.31 (C-2'
and C=N), 117.01 (C-l '), 117.90 (C-5'), 130.29 (C-
6') and 160.57 (C-3', C-3 and C-5).
X-Ray Crystallography. All measurements
were made using a Siemens P3R3 four-circle
diffractometer equipped with an Oxford
Cryosystems Cryostream Cooler (version 2.4).
Graphite monochromated Mo-Ka radiation
(1.=0.71073 A) was used to collect the intensity
data in the 00-28 mode. Unit cell parameters and
orientation matrices were obtained by least-squares
refinement of the setting angles of 15 high angle
reflections.
The crystallograrhic programme system was
SHELXTL PLUS and SHELXL-93 10; the
refinement programme used was atomic scattering
factors taken {rom International Tables for
Crystallography", The structure was solved by
direct methods and refined using full-matrix least-
squares on F2. All non-hydrogen atoms were
inserted using a riding model and given isotropic
thermal parameters equal to 1.2 (or 1.5 for methyl
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groups) times the equivalent isotropic
displacement parameter of the atom to which the H
atom is attached.
The weighting scheme was of the form w-I =
2 2 2 ( 2 )[0- (Fo) + (0.1566)] where P = [max. F, ,0 +
2Fe2]/3. The R factors are defined as Rl=~llFol-
2 2 2 2)2 1/2lFelll~IFoland wR2=[~[w(Fo -Fe) ]/~[w(Fo ]] .
A summary of the crystal data and refinement
details for compound 5 are given in Table V;
atomic coordinates and selected bond lengths and
angles are given in Tables VI and VII. Additional
material, available from the Cambridge Crystal-
lographic Data Centre includes a full list of bond
lengths and angles, thermal parameters and
hydrogen coordinates.
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